Subcutaneous testosterone pellet implant (Testopel®) therapy for men with testosterone deficiency syndrome: A single-site retrospective safety analysis

Journal of Sexual Medicine

Volumn 6, Issue 11, 2009, Pages 3177-3192

  Cavender, Richard K ^a   Fairall, Melissa ^a  

^a Ohio Center for Sexual Medicine   (United States)

Author keywords

Hypogonadism; Subcutaneous testosterone pellet implant; Testosterone; Testosterone deficiency syndrome

Indexed keywords

ANASTROZOLE; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN; TESTOPEL; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN DEFICIENCY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG IMPLANTATION; DRUG PELLET; DRUG SAFETY; EDEMA; ERYTHEMA; HEMATOCRIT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL;

EID: 70649104816     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01513.x     Document Type: Article

References (29)

1. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009, 55:121-30.
2. Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009, 30:10-22.
3. Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009, 30:23-32.
4. Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD, Lotti F, Chiarini V, Fedele D, Forti G, Maggi M. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 2007, 4:1038-45.
5. Jungwirth A, Plas E, Geurts P. Clinical experience with Andriol Testocaps-The first Austrian surveillance study on the treatment of late-onset hypogonadism. Aging Male 2007, 10:183-7.
6. Yassin AA, Haffejee M. Testosterone depot injection in male hypogonadism: A critical appraisal. Clin Interv Aging 2007, 2:577-90.
7. Jacobeit JW, Gooren LJ, Schulte HM. Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. J Sex Med 2007, 4:1479-84.
8. Saad F, Gooren LJ, Haider A, Yassin A. A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl 2008, 29:102-5.
9. Daniell HW, Lentz R, Mazer NA. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 2006, 7:200-10.
10. Dean JD, Carnegie C, Rodzvilla J, Smith T. Long-term effects of TestimR 1% testosterone gel in hypogonadal men. Rev Urol 2004, 6(6):S22-9. suppl
11. Chik Z, Johnston A, Tucker AT, Chew SL, Michaels L, Alam CA. Pharmacokinetics of a new testosterone transdermal delivery system, TDS-testosterone in healthy males. Br J Clin Pharmacol 2006, 61:275-9.
12. McNicholas T, Ong T. Review of Testim gel. Expert Opin Pharmacother 2006, 7:477-84.
13. Deansley R, Rapkes AS. Further experiments on the administration of hormones by the subcutaneous implantation of tablets. Lancet 1938, ii:606-8.
14. Conway AJ, Boylan LM, Howe C, Ross G, Handelsman DJ. Randomized clinical trial of testosterone replacement therapy in hypogonadal men. Int J Androl 1988, 11:247-64.
15. Handelsman DJ, Conway AJ, Boylan LM. Pharmacokinetics and pharmacodynamics of testosterone pellets in man. J Clin Endocrinol Metab 1990, 71:216-22.
16. Handelsman DJ, Mackey MA, Howe C, Turner L, Conway AJ. An analysis of testosterone implants for androgen replacement therapy. Clin Endocrinol Oxf 1997, 47:311-6.
17. Kelleher S, Turner L, Howe C, Conway AJ, Handelsman DJ. Extrusion of testosterone pellets: A randomized controlled clinical study. Clin Endocrinol Oxf 1999, 51:469-71.
18. Kelleher S, Conway AJ, Handelsman DJ. Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants. Clin Endocrinol Oxf 2001, 55:531-6.
19. Kelleher S, Conway AJ, Handelsman DJ. A randomised controlled clinical trial of antibiotic impregnation of testosterone pellet implants to reduce extrusion rate. Eur J Endocrinol 2002, 146:513-8.
20. Kelleher S, Howe C, Conway AJ, Handelsman DJ. Testosterone release rate and duration of action of testosterone pellet implants. Clin Endocrinol Oxf 2004, 60:420-8.
21. Zacharin MR, Warne GL. Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets. Arch Dis Child 1997, 76:495-9.
22. Jockenhövel F, Vogel E, Kreutzer M, Reinhardt W, Lederbogen S, Reinwein D. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men. Clin Endocrinol Oxf 1996, 45:61-71.
23. El-Sakka AI. Association of risk factors and medical comorbidities with male sexual dysfunctions. J Sex Med 2007, 4:1691-700.
24. Cavender RK. Subcutaneous testosterone pellet implantation procedure for treatment of testosterone deficiency syndrome. J Sex Med 2009, 6:21-4.
25. Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. J Clin Endocrinol Metab 2004, 89:1174-80.
26. T'Sjoen GG, Giagulli VA, Delva H, Crabbe P, De Bacquer D, Kaufman JM. Comparative assessment in young and elderly men of the gonadotropin response to aromatase inhibition. J Clin Endocrinol Metab 2005, 90:5717-22.
27. O'Connor DB, Corona G, Forti G, Tajar A, Lee DM, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Huhtaniemi IT, Kula K, O'Neill TW, Pendleton N, Punab M, Silman AJ. Assessment of sexual health in aging men in Europe: Development and validation of the European Male Ageing Study sexual function questionnaire. J Sex Med 2008, 5:1374-85.
28. Raynaud JP, Tichet J, Born C, Taieb C, Igigabel P, Giton F, Fiet J. Aging Male Questionnaire in normal and complaining men. J Sex Med 2008, 5:2703-12.
29. Heinemann LA. Aging Males' Symptoms scale: A standardized instrument for the practice. J Endocrinol Invest 2005, 28:34-8.